S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
Stock market today: Wall Street rises in premarket as bond markets stabilize and earnings roll in
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
J.B. Hunt Hits the Skids: Lower Prices to Come
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
Stock market today: Wall Street rises in premarket as bond markets stabilize and earnings roll in
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
J.B. Hunt Hits the Skids: Lower Prices to Come
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
Stock market today: Wall Street rises in premarket as bond markets stabilize and earnings roll in
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
J.B. Hunt Hits the Skids: Lower Prices to Come
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
Stock market today: Wall Street rises in premarket as bond markets stabilize and earnings roll in
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
United Airlines Soars on Earnings Beat
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
J.B. Hunt Hits the Skids: Lower Prices to Come
NASDAQ:LNSR

LENSAR (LNSR) Stock Price, News & Analysis

$3.06
+0.04 (+1.32%)
(As of 04/17/2024 ET)
Today's Range
$3.00
$3.25
50-Day Range
$3.02
$5.00
52-Week Range
$1.80
$5.30
Volume
5,690 shs
Average Volume
46,937 shs
Market Capitalization
$34.88 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00

LENSAR MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
161.4% Upside
$8.00 Price Target
Short Interest
Healthy
0.83% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.87 out of 5 stars

Medical Sector

711th out of 913 stocks

Surgical & Medical Instruments Industry

74th out of 95 stocks

LNSR stock logo

About LENSAR Stock (NASDAQ:LNSR)

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

LNSR Stock Price History

LNSR Stock News Headlines

Don’t expose yourself to stocks during the week
The S&P 500 just crossed below the 200 day moving average… The Nasdaq is bleeding out… Are we headed for a recession?! If you’ve been in the stock market the last few months, it hasn’t been fun… But what if I told you there was a way to target “BONUS” income just by doing a unique type of trade over the weekend? When the markets are closed. And volatility is minimal.
Analysts’ Top Healthcare Picks: 89bio (ETNB), UnitedHealth (UNH)
Biden to Launch “FedNOW” [Move Your Money Now]
Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...
LENSAR Q4 2023 Earnings Preview
Navigating 6 Analyst Ratings For Viridian Therapeutics
LENSAR Stock (NASDAQ:LNSR), Short Interest Report
LENSAR Decline Means Insider Profits Down To US$42k
LENSAR's Earnings Outlook
Will LENSAR (NASDAQ:LNSR) Spend Its Cash Wisely?
See More Headlines
Receive LNSR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LENSAR and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/04/2024
Today
4/18/2024
Next Earnings (Estimated)
5/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:LNSR
Fax
N/A
Employees
130
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$8.00
High Stock Price Target
$8.00
Low Stock Price Target
$8.00
Potential Upside/Downside
+161.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-14,380,000.00
Pretax Margin
-34.11%

Debt

Sales & Book Value

Annual Sales
$42.16 million
Book Value
$2.97 per share

Miscellaneous

Free Float
7,006,000
Market Cap
$34.88 million
Optionable
Optionable
Beta
0.47
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

LNSR Stock Analysis - Frequently Asked Questions

Should I buy or sell LENSAR stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LENSAR in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" LNSR shares.
View LNSR analyst ratings
or view top-rated stocks.

What is LENSAR's stock price target for 2024?

1 Wall Street research analysts have issued 1 year price objectives for LENSAR's shares. Their LNSR share price targets range from $8.00 to $8.00. On average, they predict the company's share price to reach $8.00 in the next year. This suggests a possible upside of 161.4% from the stock's current price.
View analysts price targets for LNSR
or view top-rated stocks among Wall Street analysts.

How have LNSR shares performed in 2024?

LENSAR's stock was trading at $3.51 on January 1st, 2024. Since then, LNSR shares have decreased by 12.8% and is now trading at $3.06.
View the best growth stocks for 2024 here
.

Are investors shorting LENSAR?

LENSAR saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 77,300 shares, an increase of 85.8% from the March 15th total of 41,600 shares. Based on an average daily trading volume, of 43,700 shares, the short-interest ratio is presently 1.8 days. Approximately 0.8% of the company's stock are sold short.
View LENSAR's Short Interest
.

When is LENSAR's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our LNSR earnings forecast
.

How were LENSAR's earnings last quarter?

LENSAR, Inc. (NASDAQ:LNSR) announced its quarterly earnings data on Monday, March, 4th. The company reported ($0.22) EPS for the quarter, meeting the consensus estimate of ($0.22). The firm earned $12.11 million during the quarter. LENSAR had a negative trailing twelve-month return on equity of 40.53% and a negative net margin of 34.11%.

How do I buy shares of LENSAR?

Shares of LNSR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:LNSR) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners